Evidence map›Paper›PMID 31344966›Full record

ReviewNutrients2019

Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions.

Maria Teresa Viggiani, Lorenzo Polimeno, Alfredo Di Leo, Michele Barone

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Multi-Anticancer Activities of Phytoestrogens in Human Osteosarcoma.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Habitual Phytoestrogen Intake Is Associated with Breast Composition in Girls at 2 Years after Menarche Onset.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maria Teresa ViggianiGastroenterology Unit, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Policlinic University Hospital, Piazza G. Cesare 11, 70124 Bari, Italy.ORCID 0000-0002-8689-9103
Lorenzo PolimenoGastroenterology Unit, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Policlinic University Hospital, Piazza G. Cesare 11, 70124 Bari, Italy.
Alfredo Di LeoGastroenterology Unit, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Policlinic University Hospital, Piazza G. Cesare 11, 70124 Bari, Italy.
Michele BaroneGastroenterology Unit, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Policlinic University Hospital, Piazza G. Cesare 11, 70124 Bari, Italy. michele.barone@uniba.it.ORCID 0000-0001-8284-5127
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phytoestrogens are natural substances that have been extensively studied for their beneficial effect on human health. Herein, we analyzed the data of the literature on the role of phytoestrogens in the prevention of colorectal neoproliferative lesions (CNL). Both in vitro and in vivo studies suggest that the beneficial effects of phytoestrogens on CNL mainly depend on their ability to bind estrogen receptor beta (ERβ) in the intestinal mucosa and counter ER-alpha (ERα) activity. Epidemiological data demonstrate a correlation between the low prevalence of CNL in Eastern populations and the consumption of soy products (phytoestrogen-enriched diet). However, both observational and interventional studies have produced inconclusive results. In our opinion, these discrepancies depend on an inadequate evaluation of phytoestrogen intake (dietary questionnaires were not aimed at establishing phytoestrogen intake) and absorption (depending mainly on the intestinal microbiota of the analyzed subjects). For this reason, in the present review, we performed an overview of phytoestrogen dietary intake and metabolism to offer the reader the opportunity for a better interpretation of the literature. Future prospective trials focusing on the protective effect of phytoestrogens against CNL should take into account both their dietary intake and absorption, considering the effective role of the intestinal microbiota.

Indexed as

Cell ProliferationDiet, HealthyRisk Reduction BehaviorAnimalsBiological AvailabilityColonColorectal NeoplasmsGastrointestinal MicrobiomeHumansNutritive ValuePhytoestrogensPrevalenceProtective FactorsRecommended Dietary AllowancesRisk AssessmentRisk FactorsPhytoestrogenscolon adenomascolorectal cancerestrogen receptorsfamilial adenomatous polyposisintestinal microbiota

Identifiers

PMID31344966
PMCPMC6722977
OpenAlexW2964016584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.